OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001582249

ACTAVIA LIFE SCIENCES, INC.

ACTAVIA LIFE SCIENCES, INC. (CIK 0001582249, EIN 39-2080103) reported revenue of $0 for FY2018 (2017-10-01 to 2018-09-30) and net income of -$4.44 million (-$4,442,535) for FY2023 (2022-10-01 to 2023-09-30), as filed in its 10-K filed 2018-12-24 (accession 0001213900-18-017775) and its 10-K filed 2024-01-05 (accession 0001213900-24-001370).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends September 30).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001582249
EIN39-2080103
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationNV
Fiscal year endSeptember 30
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_45nk2zzws2jf56q692eqzv99v5
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$0FY20182017-10-01 to 2018-09-3010-K2018-12-240001213900-18-017775RevenueFromContractWithCustomerIncludingAssessedTax
Net income-$4,442,535FY20232022-10-01 to 2023-09-3010-K2024-01-050001213900-24-001370NetIncomeLoss
Total assets$95,657FY2023as of 2023-09-3010-K2024-01-050001213900-24-001370Assets
Total liabilities$2,051,566FY2023as of 2023-09-3010-K2024-01-050001213900-24-001370Liabilities
Stockholders' equity-$1,955,909FY2023as of 2023-09-3010-K2024-01-050001213900-24-001370StockholdersEquity
Operating cash flow-$8,516FY20232022-10-01 to 2023-09-3010-K2024-01-050001213900-24-001370NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$0.01 per shareFY20232022-10-01 to 2023-09-3010-K2024-01-050001213900-24-001370EarningsPerShareDiluted
Shares outstanding771,811,360 sharesFY2023as of 2024-01-0410-K2024-01-050001213900-24-001370EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2014-2023, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20182017-10-01 to 2018-09-30$010-K2018-12-240001213900-18-017775
RevenueFY20172016-04-01 to 2017-03-31$010-K2018-12-240001213900-18-017775
Net incomeFY20232022-10-01 to 2023-09-30-$4,442,53510-K2024-01-050001213900-24-001370
Net incomeFY20222021-10-01 to 2022-09-30-$686,58810-K2024-01-050001213900-24-001370
Net incomeFY20212020-10-01 to 2021-09-30-$875,99810-K2023-02-090001213900-23-009695
Net incomeFY20202019-10-01 to 2020-09-30-$5,346,67210-K/A2022-06-100001213900-22-032089
Net incomeFY20192018-10-01 to 2019-09-30-$936,38010-K2021-01-150001213900-21-002479
Net incomeFY20182017-10-01 to 2018-09-30-$4,076,36110-K2020-01-130001213900-20-000885
Net incomeFY20172016-04-01 to 2017-03-31-$4,433,73210-K2018-12-240001213900-18-017775
Net incomeFY20162015-07-01 to 2016-06-30-$62,22710-K2016-09-280001144204-16-125830
Net incomeFY20152014-07-01 to 2015-06-30-$11,76610-K2016-09-280001144204-16-125830
Net incomeFY20142013-07-01 to 2014-06-30-$40,03510-K2015-09-280001127855-15-000394
  • Net income for FY2021 was restated: first reported as -$785,082 (accession 0001213900-22-010081, filed 2022-03-01).
  • Net income for FY2015 was restated: first reported as -$16,757 (accession 0001127855-15-000394, filed 2015-09-28).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2024-05-202024-03-310001213900-24-045020ea0206516-10q_actavia.htm
10-Q2024-02-162023-12-310001213900-24-014866f10q1223_actavia.htm
10-K2024-01-052023-09-300001213900-24-001370f10k2023_actavialife.htm
10-Q2023-08-142023-06-300001213900-23-066494f10q0623_rasnatherap.htm
10-Q2023-05-152023-03-310001213900-23-039553f10q0323_rasnatherap.htm
10-Q2023-03-022022-12-310001213900-23-016696f10q1222_rasnatherap.htm
10-K2023-02-092022-09-300001213900-23-009695f10k2022_rasnathera.htm
10-Q2022-08-222022-06-300001213900-22-050001f10q0622_rasnatherap.htm
10-Q2022-06-212022-03-310001213900-22-033764f10q0322_rasnatherap.htm
10-Q2022-06-162021-12-310001213900-22-033284f10q1221_rasnatherap.htm
10-K/A2022-06-102021-09-300001213900-22-032089f10k2021a1_rasnatherap.htm
10-K2022-03-012021-09-300001213900-22-010081f10k2021_rasnathera.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001582249published by the sourcedata.sec.gov/submissions/CIK0001582249.json2026-10-21
Employer Identification Number (EIN) · US-EIN39-2080103published by the sourcedata.sec.gov/submissions/CIK0001582249.json2026-10-21

Former names

NameFromTo
Rasna Therapeutics Inc.2016-09-272023-08-14
Active With Me Inc.2013-09-112016-09-26

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001582249.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001582249.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001582249" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001582249/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001582249/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1582249"}

On SEC EDGAR

About this data